메뉴 건너뛰기




Volumn 15, Issue 21, 2008, Pages 2099-2107

Endometriosis management: Workflow on genomics and proteomics and future biomolecular pharmacotherapy

Author keywords

Angiogenesis; Aromatase inhibitors; Endometriosis; Genetical predisposition; Genomics; GnRH agonists; Immune system; Non hormonal treatments; Proteomics

Indexed keywords

5 ETHOXYMETHOXY N HYDROXY 2 METHYL 4 (4 PHENOXYBENZAMIDO)PENTANAMIDE; ALPHA TOCOPHEROL; ALPHA2B INTERFERON; ANASTROZOLE; ANGIOGENESIS INHIBITOR; ANTIOXIDANT; AROMATASE INHIBITOR; CELECOXIB; ENDOSTATIN; ESTROGEN; ESTROGEN RECEPTOR BETA AGONIST; FUMAGILLOL CHLOROACETYLCARBAMATE; GESTAGEN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; HORMONE RECEPTOR STIMULATING AGENT; LOXORIBINE; MATRIX METALLOPROTEINASE INHIBITOR; MESOPROGESTIN DERIVATIVE; MIFEPRISTONE; ONERCEPT; ORAL CONTRACEPTIVE AGENT; PENTOXIFYLLINE; PLACEBO; PROGESTERONE RECEPTOR LIGAND; ROSIGLITAZONE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZK 137; ZK 316; HORMONE ANTAGONIST; IMMUNOLOGIC FACTOR; LIGAND;

EID: 54849163900     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986708785747571     Document Type: Review
Times cited : (8)

References (128)
  • 73
    • 53849144068 scopus 로고    scopus 로고
    • Medical management of endometriosis
    • American College of Obstetricians and Gynecologists
    • American College of Obstetricians and Gynecologists. Medical management of endometriosis. Int. J. Gynecol. Obstet., 2000, 7, 185-195.
    • (2000) Int. J. Gynecol. Obstet , vol.7 , pp. 185-195


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.